Corpus Intelligence IC Memo — SILOAM SPRINGS MEMORIAL HOSPITAL 2026-04-26 03:50 UTC
IC Memo — SILOAM SPRINGS MEMORIAL HOSPITAL
Investment Committee Memorandum | AR | 64 beds | Grade C | EBITDA uplift $6.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SILOAM SPRINGS MEMORIAL HOSPITAL

CCN 040001 | BENTON, AR | 64 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SILOAM SPRINGS MEMORIAL HOSPITAL is a 64-bed suburban community hospital in BENTON, AR with $85.0M in net patient revenue and a 8.4% operating margin. The hospital serves a payer mix of 22.7% Medicare, 11.0% Medicaid, and 66.3% commercial.

Thesis: Turnaround. Our ML models identify $6.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.4% to 15.8% (+736bps).

Net Revenue HCRIS$85.0M
Current EBITDA COMPUTED$7.2M
Operating Margin COMPUTED8.4%
Occupancy HCRIS22.1%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS17.3%
Distress Probability ML54.4%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
38
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 8.4% places it above the state median. Among 38 size-comparable peers (32-128 beds), the median margin is -3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (32-128), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SILOAM SPRINGS MEMORIAL HOSPIT (Target)AR64$85.0M8.4%
ARKANSAS HEART HOSPITALAR112$205.9M1.2%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%
BHMC-CONWAYAR108$94.7M-15.6%
NORTH ARKANSAS REGIONAL MEDICAAR120$89.1M-13.9%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ST VINCENT NORTHAR68$72.1M-18.7%
ARKANSAS METHODIST MEDICAL CENAR114$68.8M-11.8%
MEDICAL CENTER OF ARKANSASAR105$62.1M-11.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.8M+210bp18mo
Cost to Collect4.5%2.5%$1.7M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.0M+122bp9mo
Clean Claim Rate88.0%96.0%$54K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.8M
Cost to Collect
$1.7M
Denial Rate Reduction
$1.7M
A/R Days Reduction
$1.0M
Clean Claim Rate
$54K
Total EBITDA Uplift$6.3M
Current EBITDA$7.2M
+ RCM Uplift+$6.3M
Pro Forma EBITDA$13.4M
Current Margin8.4%
Pro Forma Margin15.8%
WC Released (1x)$3.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.0M$109.9M9.95x58.3%
Base (11x exit)10.0x11.0x$11.0M$124.5M11.27x62.3%
Bull Case9.0x11.0x$9.9M$148.8M14.96x71.8%
Bull (12x exit)9.0x12.0x$9.9M$165.2M16.62x75.4%
Bear Case11.0x10.0x$12.2M$75.1M6.18x43.9%
Bear (11x exit)11.0x11.0x$12.2M$86.5M7.12x48.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 22.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 32-128 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-17.6% / P50=-3.8% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.